An evaluation of five percent sulfamylon cream in control of experimental burn wound sepsis.
D000818:Animals; D001835:Body Weight; D002056:Burns / Q000188:drug therapy* / Q000401:mortality; D002452:Cell Count; D005069:Evaluation Studies as Topic; D005260:Female; D011552:Pseudomonas Infections / Q000517:prevention & control*; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D051381:Rats; D013449:Sulfonamides / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D013997:Time Factors; D014105:Tosyl Compounds / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D014870:Water Loss, Insensible / Q000187:drug effects; D014946:Wound Infection / Q000382:microbiology / Q000401:mortality / Q000517:prevention & control*
D013449:Sulfonamides; D014105:Tosyl Compounds